Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > interesting
View:
Post by spesestsemper on Jan 23, 2025 6:48am

interesting

He usually doesnt post

Dirk Arnold on LinkedIn: Thank you all at Oncolytics Biotech Inc.- a great collaboration between…



Thank you all at Oncolytics Biotech Inc.- a great collaboration between the German AIO Study Group AIO-Office in der DKG and you. And a very successful example for an excellent strategic collaboration of biotech with an investigator-driven study group. Results are looking great. Thank you so much, collaborators Dominik Modest Thomas Seufferlein Anke Reinacher-Schick Alexander Stein Eray Gkkurt Uwe Martens Prof. Dr. Jens Siveke Jack Chater Nina Burkhart (who will present results at Asklepios Krebskongress https://lnkd.in/ezeYEBPQ) and the entire team at Oncolytics Biotech Inc.
Comment by jh1970 on Jan 23, 2025 7:28am
Who is Dirk Arnold ?
Comment by m00nsh0ts on Jan 23, 2025 8:13am
He's the principal investigator in the Goblet, study.
Comment by jh1970 on Jan 23, 2025 8:14am
Thanks.
Comment by Lesalpes29 on Jan 23, 2025 8:37am
spesestsemper I appreciate your contribution here. GL everylongs 
Comment by itntdf on Jan 23, 2025 10:06am
https://www.8newsnow.com/business/press-releases/cision/20250122LN01856/oncologys-best-minds-set-to-meet-at-upcoming-2025-asco-gastrointestinal-cancers-symposium/
Oncolytics Biotech Inc